• 1. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 2. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 3. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 4. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 5. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538

Tert-butyl 4-amino-5-bromopyridine-2-carboxylate (CAS No. 868171-70-4): A Key Intermediate in Modern Pharmaceutical Synthesis

Tert-butyl 4-amino-5-bromopyridine-2-carboxylate, with the chemical identifier CAS No. 868171-70-4, is a versatile and highly valuable intermediate in the field of pharmaceutical synthesis. This compound, characterized by its pyridine core structure modified with a tert-butyl ester group, an amino group at the 4-position, and a bromine atom at the 5-position, has garnered significant attention due to its utility in the development of novel therapeutic agents.

The structural features of Tert-butyl 4-amino-5-bromopyridine-2-carboxylate make it an excellent building block for constructing complex molecular architectures. The presence of both an amino and a bromine substituent allows for further functionalization via cross-coupling reactions, such as Suzuki-Miyaura, Stille, or Buchwald-Hartwig couplings, enabling the introduction of diverse pharmacophores. Additionally, the tert-butyl ester group can be hydrolyzed to yield a free carboxylic acid, providing flexibility in subsequent synthetic steps.

In recent years, there has been a surge in research focused on developing small-molecule inhibitors targeting various disease pathways. Among these, kinases have emerged as critical therapeutic targets due to their involvement in numerous physiological and pathological processes. Tert-butyl 4-amino-5-bromopyridine-2-carboxylate has been employed as a key intermediate in the synthesis of kinase inhibitors. For instance, its brominated pyridine core can be coupled with heterocyclic scaffolds to generate potent inhibitors of tyrosine kinases, which are implicated in cancer and inflammatory diseases.

One notable application of Tert-butyl 4-amino-5-bromopyridine-2-carboxylate is in the development of inhibitors targeting Janus kinases (JAKs). JAKs play a crucial role in signal transduction pathways and have been implicated in autoimmune disorders such as rheumatoid arthritis and inflammatory bowel disease. Researchers have utilized this compound to design novel JAK inhibitors by incorporating it into the core structure of pharmacophores that exhibit high binding affinity and selectivity. The tert-butyl ester group facilitates further derivatization, allowing for fine-tuning of physicochemical properties such as solubility and metabolic stability.

Moreover, Tert-butyl 4-amino-5-bromopyridine-2-carboxylate has found utility in the synthesis of compounds targeting other therapeutic areas. For example, its structural motif has been incorporated into molecules designed to interact with nuclear receptors, which are transcription factors involved in regulating gene expression. These receptors are key targets for drugs used in treating conditions such as hyperlipidemia, type 2 diabetes, and certain types of cancer.

The versatility of Tert-butyl 4-amino-5-bromopyridine-2-carboxylate extends to its use in designing probes for biochemical studies. The presence of both an amino and a bromine group allows for selective labeling via click chemistry or other bioconjugation techniques. This feature has been exploited in developing tools for studying protein-protein interactions and enzyme mechanisms, contributing to a deeper understanding of biological pathways relevant to human health and disease.

Recent advancements in medicinal chemistry have highlighted the importance of fragment-based drug design (FBDD), where small molecular fragments are identified and then optimized to produce lead compounds. Tert-butyl 4-amino-5-bromopyridine-2-carboxylate has served as a valuable fragment in this context, providing a scaffold that can be modified to enhance binding affinity and selectivity against target proteins. Its pyridine core offers multiple sites for derivatization, allowing chemists to explore diverse chemical space efficiently.

The synthesis of Tert-butyl 4-amino-5-bromopyridine-2-carboxylate itself is an intriguing challenge that highlights the ingenuity of synthetic organic chemistry. Typically involving multi-step reactions starting from readily available precursors such as pyridine derivatives, the synthesis often requires careful optimization to achieve high yields and purity. Techniques such as palladium-catalyzed cross-coupling reactions and transition-metal-catalyzed functionalization play pivotal roles in constructing the desired molecular framework.

In conclusion, Tert-butyl 4-amino-5-bromopyridine-2-carboxylate (CAS No. 868171-70-4) is a cornerstone intermediate in modern pharmaceutical synthesis. Its unique structural features enable its use in constructing complex molecules targeting various therapeutic areas, particularly kinase inhibitors and nuclear receptor modulators. As research continues to uncover new biological targets and mechanisms, the demand for high-quality intermediates like this compound is expected to grow, driving further innovation in drug discovery and development.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)